Department of Neurology, Columbia University Medical Center, New York, NY, USA.
J Cereb Blood Flow Metab. 2012 Nov;32(11):1973-6. doi: 10.1038/jcbfm.2012.122. Epub 2012 Aug 29.
HMG-CoA reductase inhibitors (statins) are associated with improved stroke outcome. This observation has been attributed in part to the palliative effect of statins on cerebral hemodynamics and cerebral autoregulation (CA), which are mediated mainly through the upregulation of endothelium nitric oxide synthase (eNOS). Several animal studies indicate that statin pretreatment enhances cerebral blood flow after ischemic stroke, although this finding is not further supported in clinical settings. Cerebral vasomotor reactivity, however, is significantly improved after long-term statin administration in most patients with severe small vessel disease, aneurysmal subarachnoid hemorrhage, or impaired baseline CA.
羟甲基戊二酰辅酶 A 还原酶抑制剂(他汀类药物)与改善中风预后有关。这一观察结果部分归因于他汀类药物对脑血流动力学和脑自动调节(CA)的缓解作用,这主要是通过上调内皮型一氧化氮合酶(eNOS)来介导的。一些动物研究表明,他汀类药物预处理可增加缺血性中风后的脑血流,但这一发现在临床环境中并没有得到进一步支持。然而,在大多数患有严重小血管疾病、动脉瘤性蛛网膜下腔出血或基线 CA 受损的患者中,长期他汀类药物治疗后,脑血管反应性显著改善。